Stephens Inc Danaher Corp Transaction History

Stephens Inc

$6.77 Billion
Q3 2024

A detailed history of Stephens Inc transactions in Danaher Corp stock. As of the latest transaction made, Stephens Inc holds 13,992 shares of DHR stock, worth $3.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

13,992

Previous 13,953 0.28%

Holding current value

$3.2 Million

Previous $3.49 Million 11.56%

% of portfolio

0.06%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$239.25 - $280.76 $9,330 - $10,949	39 Added 0.28%	13,992 $3.89 Million
Q2 2024 Aug 06, 2024	BUY	$235.51 - $267.98 $123,642 - $140,689	525 Added 3.91%	13,953 $3.49 Million
Q1 2024 May 15, 2024	SELL	$224.58 - $256.19 $38,852 - $44,320	-173 Reduced 1.27%	13,428 $3.35 Million
Q4 2023 Feb 13, 2024	BUY	$185.1 - $233.13 $25,728 - $32,405	139 Added 1.03%	13,601 $3.15 Million
Q3 2023 Nov 14, 2023	SELL	$233.08 - $265.59 $269,673 - $307,287	-1,157 Reduced 7.91%	13,462 $3.34 Million
Q2 2023 Aug 14, 2023	SELL	$224.99 - $256.14 $1.69 Million - $1.93 Million	-7,530 Reduced 34.0%	14,619 $3.51 Million
Q1 2023 May 15, 2023	SELL	$239.75 - $277.0 $278,349 - $321,597	-1,161 Reduced 4.98%	22,149 $5.58 Million
Q4 2022 Jan 25, 2023	BUY	$241.42 - $282.29 $1.21 Million - $1.41 Million	4,996 Added 27.28%	23,310 $6.19 Million
Q3 2022 Nov 02, 2022	SELL	$247.06 - $1507.4 $45,953 - $280,376	-186 Reduced 1.01%	18,314 $4.73 Million
Q2 2022 Aug 03, 2022	BUY	$237.11 - $299.66 $30,112 - $38,056	127 Added 0.69%	18,500 $4.69 Million
Q1 2022 May 04, 2022	SELL	$257.27 - $315.76 $388,734 - $477,113	-1,511 Reduced 7.6%	18,373 $5.39 Million
Q4 2021 Mar 07, 2022	SELL	$292.08 - $329.01 $36,217 - $40,797	-124 Reduced 0.62%	19,884 $6.54 Million
Q3 2021 Oct 27, 2021	SELL	$272.21 - $332.43 $164,959 - $201,452	-606 Reduced 2.94%	20,008 $6.09 Million
Q2 2021 Aug 12, 2021	SELL	$225.08 - $271.69 $146,527 - $176,870	-651 Reduced 3.06%	20,614 $5.53 Million
Q1 2021 May 14, 2021	SELL	$212.38 - $245.9 $1.88 Million - $2.18 Million	-8,847 Reduced 29.38%	21,265 $4.79 Million
Q4 2020 Feb 10, 2021	BUY	$212.5 - $245.46 $1.23 Million - $1.42 Million	5,782 Added 23.76%	30,112 $6.69 Million
Q3 2020 Nov 13, 2020	SELL	$177.16 - $215.33 $105,764 - $128,552	-597 Reduced 2.39%	24,330 $5.24 Million
Q2 2020 Aug 24, 2020	BUY	$128.7 - $176.83 $401,801 - $552,063	3,122 Added 14.32%	24,927 $4.41 Million
Q1 2020 May 14, 2020	SELL	$121.39 - $169.05 $2.1 Million - $2.92 Million	-17,259 Reduced 44.18%	21,805 $3.02 Million
Q4 2019 Feb 14, 2020	SELL	$133.47 - $153.48 $173,511 - $199,524	-1,300 Reduced 3.22%	39,064 $6 Million
Q3 2019 Oct 18, 2019	SELL	$135.4 - $146.47 $820,388 - $887,461	-6,059 Reduced 13.05%	40,364 $5.83 Million
Q2 2019 Aug 01, 2019	BUY	$124.88 - $143.73 $60,317 - $69,421	483 Added 1.05%	46,423 $6.64 Million
Q1 2019 May 03, 2019	SELL	$97.62 - $132.29 $310,333 - $420,549	-3,179 Reduced 6.47%	45,940 $6.07 Million
Q4 2018 Feb 11, 2019	SELL	$94.85 - $109.54 $188,751 - $217,984	-1,990 Reduced 3.89%	49,119 $5.07 Million
Q3 2018 Nov 14, 2018	SELL	$98.13 - $108.9 $1.57 Million - $1.74 Million	-15,980 Reduced 23.82%	51,109 $5.55 Million
Q2 2018 Aug 10, 2018	BUY	$96.1 - $103.24 $372,291 - $399,951	3,874 Added 6.13%	67,089 $6.62 Million
Q1 2018 May 03, 2018	SELL	$92.16 - $103.8 $650,465 - $732,620	-7,058 Reduced 10.04%	63,215 $6.19 Million
Q4 2017 Feb 05, 2018	SELL	$85.26 - $94.62 $131,385 - $145,809	-1,541 Reduced 2.15%	70,273 $6.52 Million
Q3 2017 Nov 08, 2017	SELL	$79.29 - $88.45 $30,288 - $33,787	-382 Reduced 0.53%	71,814 $6.16 Million
Q2 2017 Aug 10, 2017	BUY	N/A	72,196	72,196 $6.09 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

539M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $166B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account